Which medication is used to treat dyskinesia related to Parkinson's disease therapy?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Which medication is used to treat dyskinesia related to Parkinson's disease therapy?

Explanation:
Dyskinesias arising from Parkinson’s therapy are best managed with amantadine because it works differently from dopaminergic drugs. Amantadine blocks NMDA receptors, which reduces abnormal glutamatergic activity in the basal ganglia that contributes to peak-dose dyskinesias from long-term levodopa use. This helps smooth out involuntary movements without increasing dopaminergic stimulation that can worsen dyskinesias. Other options either boost dopamine to improve symptoms (selegiline) or extend levodopa’s effect without addressing the dyskinesia itself (tolcapone and carbidopa-levodopa), and can even worsen dyskinesias over time. So amantadine specifically targets the dyskinesia mechanism, making it the best choice.

Dyskinesias arising from Parkinson’s therapy are best managed with amantadine because it works differently from dopaminergic drugs. Amantadine blocks NMDA receptors, which reduces abnormal glutamatergic activity in the basal ganglia that contributes to peak-dose dyskinesias from long-term levodopa use. This helps smooth out involuntary movements without increasing dopaminergic stimulation that can worsen dyskinesias. Other options either boost dopamine to improve symptoms (selegiline) or extend levodopa’s effect without addressing the dyskinesia itself (tolcapone and carbidopa-levodopa), and can even worsen dyskinesias over time. So amantadine specifically targets the dyskinesia mechanism, making it the best choice.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy